Diagnostics News and Research

RSS

NCI selects Arizona State University to lead new cancer research

Arizona State University has been awarded more than $8.5 million over five years from the National Cancer Institute to establish the Arizona Cancer and Evolution Center.

6 Jun 2018

KFU medical departments seek to find treatments for hereditary syndromes

Newest results were showcased at the International Myology School in Moscow on 16th - 19th May 2018. KFU was represented by Junior Research Associate Mikhail Mavlikeev.

6 Jun 2018

Patients diagnosed with high-sensitivity troponin test have lower risk of future heart attack

The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than before.

5 Jun 2018

Lonza and Innosieve Diagnostics enter into distribution agreement for innovative bioburden testing method

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of endotoxin products, services and software and provides pharmaceutical testing professionals with a comprehensive set of quality control tools.

From Lonza 5 Jun 2018

Agendia and Angsana partner to market MammaPrint, BluePrint breast cancer tests in Southeast Asia

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, and Angsana Molecular & Diagnostics Laboratory Pte Ltd, a subsidiary of Parkway Pantai, announce a partnership to market the MammaPrint Breast Cancer Risk of Recurrence test and the BluePrint Molecular Subtyping test to physicians across Southeast Asia, including Singapore, Malaysia, Vietnam, Brunei and Myanmar.

31 May 2018

Study: Sex hormone levels associated with increased risk of cardiovascular disease in older women

In an analysis of data collected from more than 2,800 women after menopause, Johns Hopkins researchers report new evidence that a higher proportion of male to female sex hormones was associated with a significant increased relative cardiovascular disease risk.

29 May 2018

Lunaphore and Vitro announce partnership to develop ISH protocols for RNA, DNA targets

Lunaphore Technologies SA, a next generation tissue diagnostics company, and Vitro SA, a manufacturer in the field of Pathology and Biomedical Research, announce today a collaboration agreement to develop In Situ Hybridization protocols for RNA and DNA targets in tissue using reagents provided by Vitro on Lunaphore’s rapid autostaining platform.

25 May 2018

$FDA authorizes marketing of OsteoDetect software for detecting wrist fractures$

FDA authorizes marketing of OsteoDetect software for detecting wrist fractures

Today, the U.S. Food and Drug Administration permitted marketing of Imagen OsteoDetect, a type of computer-aided detection and diagnosis software designed to detect wrist fractures in adult patients.

25 May 2018

Origami inspires researchers to develop new solution for tissue regeneration

Origami - the Japanese art of folding paper into shapes and figures - dates back to the sixth century. At UMass Lowell, it is inspiring researchers as they develop a 21st-century solution to the shortage of tissue and organ donors.

25 May 2018

Researchers develop new, rapid blood test to detect liver damage

Chemist Vincent Rotello at the University of Massachusetts Amherst, with colleagues at University College London (UCL), U.K., announce today that they have developed a "quick and robust" blood test that can detect liver damage before symptoms appear, offering what they hope is a significant advance in early detection of liver disease. Details appear in Advanced Materials.

24 May 2018

$2.3 million NIH grant to support new project on oxytocin neurons and social behavior

A team of Penn State researchers is planning to create a new map of the brain that will establish a neural circuit diagram of oxytocin, a compound often associated with affection and emotional behavior. Researchers hope the map will give them insight into how oxytocin in the brain drives social behavior.

24 May 2018

USC researchers develop new portable device for early-stage malaria detection

According to the World Health Organization, over 216 million people were infected with malaria in 2016, and 445,000 individuals died from the disease. The key to solving this health crisis is early-stage diagnosis when malaria therapeutics are most effective. A new prototype for a portable instrument capable early-stage malaria detection has been developed by a team of researchers at the USC Viterbi School of Engineering.

23 May 2018

Epigem's Managing Director sets the bar for life sciences industry at VentureFest

Tim Ryan, founder and Managing Director of Redcar-based Epigem, will speak about seeking to set the bar for the life sciences industry at VentureFest, Tees Valley.

23 May 2018

Health and diagnostics to soon be digitalized with advent of AI

Despite the fact that health in general globally is facing several challenges including antibiotic resistance, lack of accessible and affordable health care, rise of chronic and untreatable diseases such as dementia, there is a ray of hope in the advent of technology in healthcare.

22 May 2018

Determining the Optimal Biomarker Frequency for Biosensors

Chi-En Lin won Metrohm’s Young Chemist of the Year award for research into optimal biomarker frequencies and how it can be applied.

From Metrohm USA Inc. 22 May 2018

Specific patterns of fat distribution linked to metabolic disease, shows study

Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease and Type 2 Diabetes, according to a new study published in Obesity.

22 May 2018

New study shows declines in prostate cancer screening, diagnoses and treatment

A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well as decreases in the use of definitive treatments in men who have been diagnosed.

21 May 2018

Incorporation of AI could transform cancer diagnosis in UK - PM May

According to Prime Minister Theresa May, Artificial Intelligence (AI) is soon to change the scene in cancer and other disease diagnosis. She is to speak today in Macclesfield where she would acknowledge AI as a “new weapon” that is being used by the NHS and technology companies in research.

21 May 2018

New blood test could help avoid more than 40% of prostate biopsies, study finds

A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.

18 May 2018

Novel IR imaging offers rapid and reliable analysis of cancer tissues

Researchers at Ruhr-Universität Bochum have deployed a novel infrared (IR) microscope with quantum cascade lasers in order to analyze tissue samples taken during routine clinical procedures for colorectal cancer diagnosis.

From Daylight Solutions Inc 18 May 2018